| Literature DB >> 26929645 |
Halil Kunt1, İhsan Şentürk2, Yücel Gönül3, Mehmet Korkmaz4, Ahmet Ahsen5, Ömer Hazman6, Ahmet Bal7, Abdurrahman Genç8, Ahmet Songur3.
Abstract
BACKGROUND: In the literature, some articles report that the incidence of numerous diseases increases among the individuals who live around high-voltage electric transmission lines (HVETL) or are exposed vocationally. However, it was not investigated whether HVETL affect bone metabolism, oxidative stress, and the prevalence of thyroid nodule.Entities:
Keywords: RANK; RANKL; bone mineral density; electrical workers; electromagnetic radiation; thyroid
Year: 2016 PMID: 26929645 PMCID: PMC4758783 DOI: 10.2147/OTT.S94374
Source DB: PubMed Journal: Onco Targets Ther ISSN: 1178-6930 Impact factor: 4.147
The characteristics of the groups
| Patient features and EMA exposure | Control Group (n=47) | Study Group (n=47) |
|---|---|---|
| Age (years) | ||
| Average age | 39.05±5.85 | 38.37±7.53 |
| Minimum/maximum age | 28–52 | 29–52 |
| Work experience (years) | 17.21±6.64 | 15.89±6.72 |
| Smoking | 11/47 | 18/47 |
| Body Mass Index (kg/m2) | 26.65±4.16 | 26.21±4.67 |
| Body temperature measurements (°C) | 36.73±5.14 | 36.92±5.61 |
| Fatigue, anxiety and headaches | 16/47 | 34/47 |
| The average measurement of HVETL exposure (µT) | N/A | 0.53±0.25 |
| Mobile phone usage time | 537.46±8.47 | 504.55±7.69 |
| Hair dryer (times/week) | 1.6±0.61 | 1.1±0.77 |
| Computer use (hours/week) | 23.33±5.61 | 21.82±4.22 |
Note:
The data is given as mean ± standard deviation.
Abbreviations: EMA, electromagnetic area; HVETL, high-voltage electric transmission lines; N/A, not applicable.
Nutrition and habits of the participants
| Feature | Experimental group | Control group |
|---|---|---|
| Smoking | 15/47 | 11/47 |
| Alcohol consumption | 5/47 | 5/47 |
| Salt consumption | ||
| Salt-free | 0 | 0 |
| Low salty | 6 | 3 |
| Moderate salty | 43 | 37 |
| High salty | 0 | 0 |
| Coffee consumption (cups/day) (n) | ||
| None | 0 | 4 |
| 1 | 44 | 39 |
| 2 and over | 3 | 4 |
| Milk consumption (glasses/week) (n) | ||
| 1–4 | 43 | 42 |
| 5–8 | 4 | 5 |
| Type of Nutrition | Mixed | Mixed |
| Exercise and sports activity within the last 5 years; | ||
| Sport such as walking and weight lifting at least 3 times per week on a regular basis. | 3 | 5 |
Comparison of bone mineral density and blood chemistry parameters between the study and control group
| Measured parameters | Control group | Study group | |
|---|---|---|---|
| RANK (pg/mL) | 82.24 (4.63–263.27) | 102.21 (48.63–294.84) | |
| RANKL (pmol/L) | 322 (112–1,272) | 408.06 (191–1,262) | |
| OPG (pg/mL) | 51.98 (29.54–107.22) | 45.06 (25.35–83.85) | |
| BMD (L1–L4) | −0.16±0.93 | −1.13±0.99 | |
| BMD (FEMUR) | 0.31±1.00 | −0.63±0.84 | |
| ALP (U/L) | 76.00±19.71 | 88.04±22.25 | |
| P (mg/dL) | 2.80±0.41 | 3.43±0.37 |
Notes:
Mann–Whitney U-test was used for binary comparisons between groups in these data, and the values were given as median (minimum–maximum). t-test (independent samples t-test) for independent samples was applied in other data and values were given as mean ± standard deviation.
Abbreviations: OPG, osteoprotegerin; BMD, bone mineral density; ALP, alkaline phosphatase; P, phosphor.
Figure 1Distribution of RANK values in the study and control groups.
Figure 2Distribution of RANKL values in the study and control groups.
Figure 3Distribution of OPG values in the study and control groups.
Abbreviation: OPG, osteoprotegerin.
Comparison of thyroid function tests and thyroid’s diameter measurements between groups
| Measured parameters | Control group | Study group | |
|---|---|---|---|
| FT3, mean ± SD | 3.34±0.32 | 3.22±0.51 | 0.302 |
| FT4, mean ± SD | 1.21 (0.92–2.67) | 1 (0–3.19) | |
| TSH | 1.66 (0.48–4.34) | 1.41 (0.01–7.72) | 0.180 |
| RapD | 16.15 (12.5–24) | 18 (8–37) | 0.056 |
| LapD | 15.6 (12.1–24.3) | 17 (10–30) | |
| Istmus D | 3.35 (2.20–5.9) | 3.3 (1–13) | 0.647 |
Notes:
Independent t-test and
Mann–Whitney U-test was applied. The data were presented as median (minimum–maximum) unless stated otherwise. Bold P-value shows the difference was statistically significant (P<0.05).
Abbreviations: RapD, right anteroposterior diameter; LapD, left anteroposterior diameter; Istmus D, tiroid istmus diameter; TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; SD, standard deviation.
Comparison L1–L4 and femoral BMD values with the DEXA results as per study group’s ages
| Bone type | Age (years) | N | T-score | |
|---|---|---|---|---|
| L1–L4 | 20–29 | 4 | −1.35±0.65 | |
| 30–39 | 24 | −0.97±0.53 | 0.504 | |
| 40–49 | 15 | −1.28±0.57 | 0.904 | |
| 50 and older | 4 | −1.28±0.62 | 0.918 | |
| Femur | 20–29 | 4 | −1.02±0.51 | |
| 30–39 | 24 | −0.39±0.48 | 0.167 | |
| 40–49 | 15 | −0.88±0.58 | 0.770 | |
| 50 and older | 4 | −0.78±0.34 | 0.674 |
Note: Independent t-test was applied. The data were given as mean ± standard deviation.
Abbreviations: BMD, bone mineral density; DEXA, dual-energy X-ray absorptiometry; t-test, independent samples t-test.
Comparison L1–L4 and femoral BMD values with the DEXA results according to work experience
| Bone type | Work experience (years) | N | T-score | |
|---|---|---|---|---|
| L1–L4 | 10–19 | 32 | −1.02±0.55 | 0.255 |
| 20 and older | 15 | −1.36±0.76 | ||
| Femur | 10–19 | 32 | −0.44±0.28 | 0.021 |
| 20 and older | 15 | −0.94±0.51 |
Notes:
Independent t-test was applied. Bold P-value defines the significant difference (P<0.05). The data were given as mean ± standard deviation.
Abbreviations: BMD, bone mineral density; DEXA, dual-energy X-ray absorptiometry.
Comparison of the bone biochemistry parameters according to work experience
| Biochemistry parameter | Work experience (years) | N | Mean | |
|---|---|---|---|---|
| Ca | 10–19 | 32 | 9.27±0.27 | 0.872 |
| 20 and older | 15 | 9.29±0.50 | ||
| P (mg/dL) | 10–19 | 32 | 2.85±0.44 | 0.281 |
| 20 and older | 15 | 2.71±0.31 | ||
| ALP (U/L) | 10–19 | 32 | 84.93±13.63 | |
| 20 and older | 15 | 94.67±23.63 | ||
| Creatine (mg/dL) | 10–19 | 32 | 0.90±0.11 | 0.69 |
| 20 and older | 15 | 0.89±0.08 | ||
| RANK (pg/mL) | 10–19 | 32 | 96.89±41.96 | 0.182 |
| 20 and older | 15 | 113.56±82.20 | ||
| RANKL (pmol/L) | 10–19 | 32 | 391.33±109.84 | 0.166 |
| 20 and older | 15 | 443.78±168.88 |
Notes:
Independent t-test was applied. Bold P-value defines the significant difference (P<0.05). The data were given as mean ± standard deviation.
Abbreviations: ALP, alkaline phosphatase; P, phosphor.
Comparison of serum oxidative stress index between groups
| Oxidative stress parameters | Control group | Study group | |
|---|---|---|---|
| TAS (mmol Trolox Equiv/L) | 1.93 (0.40–3.73) 0.84 | 1.62 (0.16–3.96) | |
| TOS (µmol H2O2 equiv/L) | 7.63±3.10 | 9.39±3.68 | |
| OSI (AU) | 487.82±462.29 | 957.32±1,201.97 |
Notes:
Independent t-test,
Mann–Whitney U-test. Data are median (minimum–maximum) unless otherwise indicated. Bold P-value defines the significant difference (P<0.05).
Abbreviations: TAS, total antioxidant status; TOS, total oxidant status; OSI, oxidative stress index.